The effect of phospholipase C (EC 3.1.4.3) on human blood platelets has been studied. Phospholipase C from Bacillus cereus was purified to homogeneity as judged by analytical and sodium dodecyl sulphate disc gel electrophoresis and by immunoelectrophoresis. Human platelets isolated from platelet-rich plasma by gel filtration or by centrifugation and washing were incubated with phospholipase C. A loss of 20-45% of the total platelet phospholipid was observed, whereas 88% was hydrolyzed when platelet homogenates were submitted to identical enzyme treatment. Intact platelets lost 50-75% phosphatidylethanolamine, 20-50% phosphatidylcholine, and 20-25% phosphatidylserine. Sphingomyelin was not a substrate for the enzyme under the conditions used. The platelets contained no detectable endogenous phospholipase C activity. The loss of phospholipid was not accompanied by aggregation of the platelets, nor did the platelets lose their ability to aggregate with ADP or thrombin. Total platelet factor 3 releasable by freezing and thawing was reduced. Measurements of releasable platelet factor 4 and the efflux of serotonin showed that no release reaction was triggered even when up to 45% of the total phospholipid in the platelets was hydrolyzed. When sphingomyelinase was added together with, before, or after phospholipase C, aggregation occurred. Sphingomyelinase alone gave no aggregation. The gel-filtered platelets also aggregated upon addition of purified phospholipase C from Clostridium perfringens. A B S T R A C T The effect of phospholipase C (EC 3.1.4.3) on human blood platelets has been studied. Phospholipase C from Bacillus cereus was purified to homogeneity as judged by analytical and sodium dodecyl sulphate disc gel electrophoresis and by immunoelectrophoresis. Human platelets isolated from platelet-rich plasma by gel filtration or by centrifugation and washing were incubated with phospholipase C.
INTRODUCTION
Recently, Schick and Yu (1) reported that a commercially available preparation of phospholipase C (EC Received for publication 29 September 1975 and in revised form 26 January 1976.
3.1.4.3) (PLC)1 from Clostridium perfringens caused
the release reaction of platelets, together with the hydrolysis of platelet phospholipids, which were situated at or near the active site or "receptor" on the platelet surface and functioned as the modulator for the release reaction. Chap and Douste-Blazy (2) found essentially the same in similar experiments using the C. perfringens phospholipase C from another commercial source. However, neither of these enzyme preparations was pure; hence it was of interest to examine the effects of a highly purified, electrophoretically homogeneous PLC from B. cereus. The latter enzyme differs from the C. perfringens enzyme in that it does not attack sphingomyelin under the conditions used here.
METHODS
Materials. ADP, sodium salt, albumin, and apyrase (Grade A) were obtained from Sigma Chemical Co., St. Louis, Mo. Bovine thrombin was obtained from HoffmanLa Roche, Basel, Switzerland. Human fibrinogen (90% clottable) from Kabi, Stockholm, Sweden, was dissolved in 0.15 M sodium chloride. Casein was obtained from Merck AG, Inc., Darmstadt, Germany. Sepharose 2B was obtained from Pharmacia AB, Uppsala, Sweden. PLC (C. perfringens) was purified and characterized as described by Mollby and Wadstr0m (3) . Sphingomyelin phosphodiesterase (SMase) (Staphylococcus aureus) (EC 3.1.4.12) was purified and characterized as described by Wadstrom and Mollby (4, 5) and M6llby and Wadstrom (6) . Both enzymes were kindly donated by Dr. Roland M6llby, Karolinska Institutet, Stockholm, Sweden.
Preparation of platelet suspension. Human platelets were prepared from blood drawn from fasting donors into plastic equipment containing 0.1 vol of acid citrate-dextrose anticoagulant (7) . Platelet The platelets were separated from the plasma proteins as described (8) by the gel filtration method of Tangen and Berman (9) . The platelets were eluted with a solution containing 1 part 0.14 M NaCi and 9 parts 0.145 M Tris-HCI, pH 7.6, with 0.1% glucose, 50 AtM CaCl2, 0.98 mM MgC12, 5.4 mM KCl, 1.5 g/100 ml of albumin, and 5 mg/ 100 ml of apyrase. The albumin preparation contained less than 0.3% phospholipid. Platelets were also prepared by washing and centrifugation as described by Mustard et al. (10) . Platelet-poor plasma was obtained by centrifugation at 12,000 g for 10 min at 4VC. Platelets were counted in a Thrombocounter (Coulter Electronics Ltd., Harpenden, England).
PLC. The enzyme (PLC) was purified from the culture filtrate of B. cereus ATCC 10987 AB-1 (11) by affinity chromatography as described earlier (12) . The enzyme preparations were homogeneous in analytical disc electrophoresis and sodium dodecyl sulfate electrophoresis. When injected into goats and rabbits, they gave rise to antisera which were monospecific in immunoelectrophoresis against purified PLC as well as against a concentrate of crude bacterial culture supernate. Extractions of lipids. The centrifuged platelets were suspended in 1 ml 0.15 M saline, and lipids were extracted with methanol and chloroform (2: 1) according to the method of Vikrot (14), with 5 ml of saturated NaCl in the procedure instead of CaCl2 (15) . In three experiments this extraction method was compared with that of Folch et al. (16) , as modified by Marcus et al. (17) , except that NaCl was used instead of CaCl2. No significant differences were found.
Phospholipid fractionation. The phospholipid distribution was determined by thin-layer chromatography with 0.5 mm silica gel H (Merck) on glass plates measuring 20 X 6 cm or 20 X 20 cm. The plates were activated at 1200C for 80 min before use, and the solvent system was chloroform: methanol: glacial acetic acid: water, 65: 25: 8: 4 by vol (18) . The chromatography was done in nonequilibrated chambers since this in our hands gave a better separation. The plates were sprayed with dichlorofluorescein (Merck), and the spots were scraped off into sintered glass tubes. The phospholipids were eluted with chloroform: methanol: glacial acetic acid: water, 50: 39: 1: 10, and dichlorofluorescein was extracted by using 4 M NH4OH followed by 50%o 2 Otnaess, A.-B. Unpublished observations. methanol in water, as described by Arvidson (19 (22) with 0.1 ml activated human plasma plus 0.1 ml test material. Platelet-poor human plasma was activated with 30 mg Celite/ml (Johns-Manville, New York) (22) . A standard curve was prepared with dilutions of a suspension of three times frozen and thawed platelets (3.7 X 10' platelets/ml) as source of PF-3.
PF-4. Aliquots of the incubation mixture were centrifuged (12,000 g/10 min/22°C), and the supernates were frozen before testing by the electroimmunoassay method of Gjesdal (23) . Standards of purified PF-4 were included for comparison. Total PF-4 was determined after addition of 2.5% Triton X-100 and freezing and thawing the platelets once, as well as after freezing and thawing three times. Activity is expressed as units of heparin neutralized.
Serotonin (SHT) efflux. The effect of PLC on 5HT efflux was investigated as described by Lingjaerde (24) (25) and by Laemmli (26) . Immunoelectrophoresis was carried out as described by Scheidegger (27) Phospholipids. In good accordance with data of others (30, 31) , the platelets were found to contain 10.0-13.9 ug lipid phosphorus/109 platelets. The composition of the phospholipid fraction is given in Table II . Our data agree reasonably well with data in the literature (31) (32) (33) (34) (35) (36) (37) (38) (39) . A small amount of phosphatidylinositol was detectable but was not quantified. Control extractions of phospholipids from platelets isolated by centrifugation and washing showed no significant differences from the data in Table II . The phospholipid fraction contained 43.5% phosphatidylcholine (PC) and 15.8% SM. The phospholipid content of the platelets was reduced after treatment with PLC, the reduction depending on the amount of PLC added when small amounts of enzyme were used (Fig. 2) . The release of lipid phosLight transmi ssion 0r Fibrinogen. phorus from intact platelets reached a plateau value of 30-45%. Essentially no further increase was seen even when 4-10 times more enzyme was used (Fig. 2) . On the other hand, when sonicated platelets were incubated with PLC (16.4 i'g PLC/108 platelets), about 85% of the total platelet phospholipid was hydrolyzed, indicating that an almost total breakdown of all phospholipids except SM, which is not a substrate, took place when the internal phospholipids were made accessible to the enzyme. There were no significant differences between the phospholipid composition of intact control platelets and that of sonicated control platelets, indicating that no endogenous phospholipase activity appeared in the platelets after sonication. In the intact platelets, only about 40% of the total phospholipid was hydrolyzed, with the different phospholipids being hydrolyzed to differing extents (Fig. 3) . Phosphatidylethanolamine (PE) was the most susceptible to hydrolysis (50-75%), followed by PC (20-50%) and phosphatidylserine (PS) (20%), while SM was not attacked. The amount of SM recovered after PLC treatment appeared to increase 5-10%. The hydrolyses of the individual phospholipids reached a plateau value that was not further increased 100. pg PLC/108 pLateLets FIGURE 2 Effect of PLC on the total phospholipid content of intact platelets. The platelet suspensions were centrifuged after incubation with PLC or buffer. Lipid was extracted with chloroform/methanol and phosphate determined after digestion.
by increasing amounts of enzyme (Fig. 3) . With SMase only 20-25% of the total platelet SM was hydrolyzed.
Efflux of serotonin. Monitoring the efflux of ["C]-
5HT from preloaded platelets showed that incubation with PLC did not trigger any release of 5HT. The efflux curve (Fig. 4) showed the same slow efflux as seen with the preloaded control platelets. The only difference was that with the PLC-treated platelets the efflux was reproducibly about 3% higher at all time points.
Lactic acid dehydrogenase. 3.7 X 108 platelets were incubated for 20 min at 370C with 19 ig PLC. No release of lactic acid dehydrogenase (EC 1.1.1.27) from the platelets to the supernate was observed.
DISCUSSION
The present study demonstrates that gel-filtered human platelets may lose up to at least 45% of their total phospholipid without induction of aggregation, or release or significant impairment of their response to ADP, thrombin, or collagen. The platelets fully retained their sensitivity and response to thrombin. The response to ADP was slightly reduced in most experiments, but the decrease did not correlate with the amount of phospholipid hydrolyzed and was therefore probably not related to the enzymatic activity. The response to collagen showed variations similar to those of the ADP response. These findings are in apparent contrast to the results of Schick and Yu (1), who found that crude PLC (C. perfringens) induced a release reaction when only a small amount (5-10%) of the phospholipid had been hydrolyzed. The corresponding loss of PC was 25% and of SM 9%. Chap and Douste-Blazy (2) reported essentially similar experiments with a similar preparation of PLC (C. perfringens) and obtained basically the same results.
We confirm their results with regard to the ability of the C. perfringens enzyme to aggregate platelets. Both PC and SM are good substrates for this enzyme (40) , whereas the Bacillus enzyme did not hydrolyze SM under the present reaction conditions. An extensive hydrolysis by the Bacillus enzyme of PE (up to 60-75%), of PC (about 50%), and of PS (20%) was not enough to induce platelet aggregation or release. Aggregation was observed only when gel-filtered platelets were treated with the Clostridium enzyme or with SMase and the Bacillus enzyme in combination or in sequence. This clearly demonstrates that even when extensive hydrolysis of the other phospholipids occurs, some SM (about 20-25%) must be hydrolyzed for aggregation and release to take place. When a certain degradation of the other phospholipids has taken place, this small degree of hydrolysis of SM (3.5-4 (42) that about 10% of PF-4 is bound to the plasma membrane. The 2-4% released by PLC may derive from this fraction.
The efflux of ["4C]5HT from preloaded platelets also showed only a very slight increase (3%) in the presence of PLC, in contrast to the situation when a release reaction takes place and about 70-85% of total platelet 5HT appears in the supernate in less than 40 s (43) . The parallel course of the efflux curves (Fig. 4) suggests that there was probably no difference in the efflux from the main intracellular pool of 5HT in the PLCtreated and in the control platelets. The small constant 3% difference remains unexplained, but may possibly be due to loss of a small plasma membrane-bound fraction of 5HT. In conclusion, both the PF-4 and the ["4C]5HT determinations indicate that no release reaction is induced by the Bacillus enzyme.
The loss of phospholipids reached a plateau of 30-45% when intact platelets were exposed to PLC and this loss pg PLC/108 plateLets FIGURE 3 Effect of phospholipase C on phospholipids in platelets. Platelet suspension was centrifuged after incubation with PLC or buffer. Lipid was extracted with chloroform/methanol. The phospholipids were separated by thinlayer chromatography, the individual spots were scraped off and eluted and phosphate was determined after digestion. was not increased further by increasing the amount of enzyme. A similar figure was found when platelets isolated by centrifugation and washing were used. The hydrolysis of the various phospholipids also reached different plateau levels (Fig. 3) , whereas in platelet sonicates the phospholipids were completely hydrolyzed by the same amounts of enzyme. Taken together with the absence of release of PF-4 and 5HT and the lack of lactic acid dehydrogenase leakage from the platelets, these findings strongly suggest that only the phospholipids of the outer layers of the platelet membrane (except SM) are accessible to the enzyme and that the PLC attack was limited to the outside of the membrane. This is in accordance with observations in other systems (41, 44 hydrolyzed 20-25% of SM. From the same reasoning, this fraction must be located in the external membrane to be available to the enzyme. The estimate of phospholipid distribution (Fig. 5 ) based on these assumptions and considerations is obviously not accurate in detail, but demonstrates the asymmetry in the platelet plasma membrane. The main difference from results obtained with other membranes (41, 44, 45) is that more PE seems to be located to the outer plasma membrane layer in the platelets. This feature may be related to the special origin of platelets and correlates nicely with the well-known procoagulant activity of PE and PS + PE, thought to be responsible for the PF-3 activity (46) . PF-3 as defined here is generally assumed to be partly localized in the plasma membrane (available PF-3) and partly in the interior of the platelet, being made available during the release reaction. The decrease in total PF-3 activity after PLC treatment must mean that the main part of the structures carrying the PF-3 activity are accessible to PLC, i.e. if our interpretation of the present data is correct, they are localized in the plasma membrane. The exact nature of these structures is currently unknown, although Vecchione and Zucker (47) recently have produced evidence that phospholipids alone can substitute completely for platelets in a plasma recalcification system. 
